ReviewJapanese journal of ophthalmology2025
Dacryoendoscopy as a frontier technology for lacrimal drainage disorders.
Review in Japanese journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Endoluminal lacrimal duct recanalization for pediatric lacrimal duct obstruction: etiologic spectrum and surgical outcomes.Japanese journal of ophthalmology · 2026Article
- Q-Needle-Assisted Intraductal Injection Enhances Dacryoendoscopic Surgery for Primary Acquired Lacrimal Drainage Obstruction: A Retrospective Study.Journal of clinical medicine · 2026Article
- Endoluminal lacrimal duct recanalization for pediatric secondary acquired lacrimal duct obstruction following epidemic keratoconjunctivitis.Japanese journal of ophthalmology · 2026Observational
- Restenosis After Lacrimal Stent Intubation in a Patient With Indigo Carmine Positivity: A Case Report.Cureus · 2025Article
- From pixels to precision: Imaging technologies shaping oculofacial plastic surgery practice.Taiwan journal of ophthalmologyReview
- Dacryoendoscopy: Historical development, philosophical foundation, and clinical perspective.Taiwan journal of ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dacryocystorhinostomy (DCR) for adult patients with acquired nasolacrimal duct obstruction can be performed via 2 approaches: an external nasal approach from the skin and an internal nasal approach from the nasal cavity. Both techniques have a history of over 100 years and are the gold standard approaches for the treatment of nasolacrimal duct obstructions. Alternatively, researchers have also attempted lacrimal passage reconstruction using various stents to restore the patency of the lacrimal passage, with nunchaku-type silicone tubes showing good surgical results according to several published reports. However, in cases in which the procedure required blind manipulation, the results were largely dependent on the surgeon's skill. Under such circumstances, the dacryoendoscope was introduced at the beginning of this century and is currently widely used. In other fields, especially in gastroenterology, the introduction of gastrointestinal endoscopes that enable observation and treatment of lesions under direct observation has dramatically improved the treatment of gastrointestinal disorders. Considering that the dacryoendoscope has become standardized over the past 20 years since its introduction, this review summarizes the current status of lacrimal passage treatment using the dacryoendoscope.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.